2021 annual financial data
Rein Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -26,605 USD and net income was -26,164 USD.
Operating cash flow was -23,754,000 USD.
Get free Rein Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -26,605 USD
- Net income
- -26,164 USD
- Operating cash flow
- -23,754,000 USD